Companies: 10,795·Total market cap: $144.5T
Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.

ARQTNASDAQHealthcare● Active
$21.54
+$0.31(+1.46%)
Market Cap$2.7B
P/E Ratio
52W High$31.77
52W Low$12.72
Overview

Arcutis Biotherapeutics, Inc.(ARQT)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ARQT · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.38B$0.20B$0.06B$0.00B$0.00B
Cost of Revenue$0.04B$0.02B$0.00B$0.00B$0.00B
Gross Profit$0.34B$0.18B$0.05B$0.00B($0.00B)
Gross Margin %(computed)90.24%90.27%91.63%79.54%
Operating Expenses
R&D Expenses$0.08B$0.08B$0.11B$0.18B$0.15B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.06B
Total Operating Expenses$0.35B$0.31B$0.30B$0.30B$0.21B
Operating Income($0.01B)($0.13B)($0.24B)($0.30B)($0.21B)
Operating Margin %(computed)-3.25%-65.33%-404.49%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.01B$0.03B$0.03B$0.02B$0.00B
Income Before Tax($0.01B)($0.14B)($0.26B)($0.31B)($0.21B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.02B)($0.14B)($0.26B)($0.31B)($0.21B)
Net Margin %(computed)-4.29%-71.25%-439.79%
Per Share & EBITDA
EPS (Basic)$-0.13$-1.16$-3.78$-5.66$-4.17
Wtd Avg Shares0.13B0.12B0.07B0.06B0.05B
EBITDA$0.00B($0.11B)($0.23B)($0.29B)($0.21B)
EBITDA Margin %(computed)0.66%-55.78%-381.56%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Arcutis Biotherapeutics, Inc.

关于Arcutis Biotherapeutics, Inc.(ARQT)损益表

Arcutis Biotherapeutics, Inc.(ARQT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ARQT实现营收$0.38B,毛利润$0.34B(毛利率90.24%),净利润($0.02B)(净利率-4.29%)。

常见问题

ARQT · 4 问

Arcutis Biotherapeutics, Inc.(ARQT)2025财年营收为$0.38B,同比up91.3%。

ARQT revenueARQT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08